查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1601291

STD 检测市场：按类型、按产品类型、按测试设定、按适应症、按最终用户 - 2025-2030 年全球预测

STD Testing Market by Type (Blood Tests, Lumbar Puncture, Swab Tests), Product Type (Instruments, Reagents & Kits), Test Settings, Indication, End-user - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年性病检测市场价值为94.4亿美元，预计到2024年将达到99.7亿美元，复合年增长率为5.90%，到2030年将达到141.1亿美元。

性病检测市场包括各种旨在检测性行为感染传染病的诊断检测，包括但不限于披衣菌感染、淋病、爱滋病毒和梅毒。感染率上升、公众健康意识提高以及早期诊断和治疗性介入的努力推动了对性病检测的需求。其应用涵盖医院、诊所和居家照护，最终用户是医疗保健提供者、个人消费者和公共卫生机构。该市场受到许多因素的显着影响，例如实现快速准确检测的技术进步、政府对性病检测宣传活动的支持力度加大以及对家庭和数位医疗保健解决方案的接受程度不断提高。这些因素为市场参与企业在远端医疗整合、基于行动应用程式的测试解决方案以及开发更灵敏和特异性的检测等领域创造了创新机会。然而，市场成长受到围绕性传染病的耻辱、欠发达地区缺乏认识以及监管核准和报销政策问题的限制。为了解决这些问题，公司可以投资教育行销宣传活动，与公共卫生机构合作，并专注于研究具有成本效益的检测解决方案。创新的关键领域包括小型化诊断平台，用于在资源有限的环境中进行测试，以及将人工智慧应用于性病感染模式的预测分析。此外，透过培养与科技公司的伙伴关係，我们可以进一步增强准确测试服务的提供。市场的动态本质需要敏捷性和远见，而多重测试和个人化医疗服务等新趋势需要高度关注。跟上医疗保健资金筹措的监管变化和潜在政策变化对于永续业务成长和竞争力至关重要。

主要市场统计
基准年[2023] 94.4亿美元
预测年份 [2024] 99.7亿美元
预测年份 [2030] 141.1亿美元
复合年增长率（%） 5.90%

市场动态：揭示快速发展的性病检测市场的关键市场洞察

供需的动态交互作用正在改变性病检测市场。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，并了解消费行为及其对製造成本的影响，并更清楚地了解对采购趋势的影响。

  • 市场驱动因素
    • 全球性行为感染感染的发生率和盛行率不断上升
    • 透过教育宣传活动提高对性传染病的认识
  • 市场限制因素
    • 有关核准性病检测产品的严格监管指南的问题
  • 市场机会
    • 性病诊断技术不断进步
    • 加大全国筛检检测力度，促进性病检测的采用
  • 市场挑战
    • 前往专门从事性病检测的诊所会带来社会耻辱

波特五力：驾驭性病检测市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解性病检测市场的外部影响

外部宏观环境因素对性病检测市场的表现动态起着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解性病检测市场的竞争状况

STD 测试市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵STD侦测市场供应商绩效评估

FPNV定位矩阵是评估STD检测市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。四个象限清楚且准确地划分供应商，帮助使用者辨识最能满足其策略目标的合作伙伴和解决方案。

本报告提供了涵盖关键重点领域的全面市场分析：

1. 市场渗透率：对当前市场环境的详细回顾，包括行业主要企业的大量资料。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 全球性行为感染传染病的发生率和盛行率不断增加
      • 透过教育宣传活动提高对性行为感染的认识
    • 抑制因素
      • 核准性病检测产品的严格监管指南存在问题
    • 机会
      • 性行为感染传染病诊断技术不断进步
      • 增加全国的筛检检测并鼓励采用性病检测
    • 任务
      • 与看专科医生相关的社会耻辱
  • 市场区隔分析
    • 类型：STD 检测 拭子检测越来越受欢迎，因为它们是非侵入性的
    • 产品类型：需要用于大容量测试环境的高通量设备
    • 测试设定：优先进行 POC 测试，以获得无与伦比的便利性和速度
    • 适应症：披衣菌感染发病率增加以及对先进检测技术的需求
    • 最终用户：扩大诊断中心性病检测的使用并减少週转时间
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章性病检测市场：依类型

  • 验血
  • 腰椎穿刺
  • 拭子测试
  • 尿液检查

第七章性病检测市场：依产品类型

  • 装置
  • 试剂和套件

第八章性病检测市场（依检测环境）

  • 实验室
  • 照护现场

第九章性病检测市场（按适应症）

  • 披衣菌感染
  • 生殖器疱疹
  • 淋病
  • B型肝炎
  • 爱滋病毒/爱滋病
  • 人类乳突病毒
  • 梅毒

第 10 章 STD 检测市场：依最终用户分类

  • 诊断中心
  • 医院/诊所

第十一章 南北美洲性病检测市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十二章亚太地区性病检测市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十三章 欧洲、中东和非洲性病检测市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第14章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • 策略伙伴关係推进性行为感染传染病自检解决方案
    • imaware 透过收购 binx health 的消费者部门扩大产品组合
    • FDA核准先进的披衣菌感染和淋病家庭检测
    • 英国Start-Ups推出性行为感染感染测试功能的卫生棉条
    • iHealth 推出 STD 检测的家庭采集套件
    • Aptitude Medical Systems 消除性行为感染感染 (STI) 的创新方法
    • LifeCell International 透过家用检测套组彻底改变了性行为感染传染病和 HPV 检测
    • Linear Diagnostics 开创性的 20 分钟淋病和披衣菌感染检测
    • 美国 BioTek 创新的家庭检测解决方案
    • Visbee Medical 先进性健康诊断工具获得 FDA 批准
    • Mylab 推出性行为感染传染病快速检测系列
    • Maternova 和 Medmira 策略联盟加强全球感染疾病快速诊断检测
    • 创新伙伴关係关係透过家庭检测解决方案来应对 Z 世代性行为感染感染激增问题
    • Meridian Biosciences 与 SD Biosensors 和 SJL Partners 合作

公司名单

  • Abbott Laboratories
  • Accuquik by AdvaCare Pharma
  • Alpine Biomedicals Pvt. Ltd.
  • ARCpoint Labs
  • Becton, Dickinson and Company
  • Bio Lab Diagnostics（I）Private Limited
  • Bio-Rad Laboratories, Inc.
  • bioMerieux SA
  • BioReference Health, LLC by OPKO HEALTH, INC.
  • Danaher Corporation
  • Daye Limited
  • Everlywell, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Getein Biotech, Inc.
  • Grifols, SA
  • Hologic, Inc.
  • JAL Medical by OK Biotech Co. Ltd.
  • Laboratory Corporation of America Holdings
  • LifeCell
  • Lorne Laboratories Limited by Calibre Scientific
  • Meridian Bioscience Inc. by SD Biosensor, Inc.
  • OraSure Technologies, Inc.
  • Personalabs
  • Qiagen NV
  • Quest Diagnostics, Inc.
  • Randox Laboratories Ltd.
  • Seegene Inc.
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc.
  • Viatris Inc.
  • Wondfo Biotech Co., Ltd.
Product Code: MRR-69324464D0F2

The STD Testing Market was valued at USD 9.44 billion in 2023, expected to reach USD 9.97 billion in 2024, and is projected to grow at a CAGR of 5.90%, to USD 14.11 billion by 2030.

The STD testing market encompasses a wide array of diagnostic tests designed to detect sexually transmitted diseases, including, but not limited to, chlamydia, gonorrhea, HIV, and syphilis. The necessity for STD testing stems from rising infection rates, greater public health awareness, and initiatives for early diagnosis and treatment intervention. Its application spans hospitals, clinics, and homecare settings, with end-users comprising healthcare providers, individual consumers, and public health organizations. The market is significantly influenced by factors such as technological advancements enabling rapid and accurate testing, increased government support for STD testing campaigns, and growing acceptance of at-home and digital healthcare solutions. These factors create opportunities for market players to innovate in areas such as telehealth integration, mobile app-based testing solutions, and the development of more sensitive and specific assays. However, market growth is challenged by limitations such as stigma surrounding STDs, lack of awareness in underdeveloped regions, and issues related to regulatory approvals and reimbursement policies. To address these, businesses could invest in educational marketing campaigns, collaborate with public health entities, and focus on research for cost-effective testing solutions. Key areas of innovation include the miniaturization of diagnostic platforms for testing in resource-limited settings and the application of AI for predictive analyses in STD transmission patterns. Additionally, fostering partnerships with technology firms can further enhance the delivery of precise testing services. The market's dynamic nature necessitates agility and foresight, with significant attention needed on emerging trends like multiplex testing and personalized healthcare delivery. Keeping pace with regulatory changes and potential policy shifts in healthcare funding will be essential for sustained business growth and establishing a competitive edge.

KEY MARKET STATISTICS
Base Year [2023] USD 9.44 billion
Estimated Year [2024] USD 9.97 billion
Forecast Year [2030] USD 14.11 billion
CAGR (%) 5.90%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving STD Testing Market

The STD Testing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising incidence and prevalence of sexually transmitted diseases worldwide
    • Increasing awareness about STDs through education campaigns
  • Market Restraints
    • Issues regarding strict regulatory guidelines for approval of STD testing products
  • Market Opportunities
    • Ongoing technical advancements in STD disease diagnostics
    • Increasing implementation of nationwide screening tests to encourage the adoption of STD testing
  • Market Challenges
    • Social stigma associated with visiting specialized STD testing clinics

Porter's Five Forces: A Strategic Tool for Navigating the STD Testing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the STD Testing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the STD Testing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the STD Testing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the STD Testing Market

A detailed market share analysis in the STD Testing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the STD Testing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the STD Testing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the STD Testing Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Accuquik by AdvaCare Pharma, Alpine Biomedicals Pvt. Ltd., ARCpoint Labs, Becton, Dickinson and Company, Bio Lab Diagnostics (I) Private Limited, Bio-Rad Laboratories, Inc., bioMerieux SA, BioReference Health, LLC by OPKO HEALTH, INC., Danaher Corporation, Daye Limited, Everlywell, Inc., F. Hoffmann-La Roche Ltd., Getein Biotech, Inc., Grifols, S.A., Hologic, Inc., JAL Medical by OK Biotech Co. Ltd., Laboratory Corporation of America Holdings, LifeCell, Lorne Laboratories Limited by Calibre Scientific, Meridian Bioscience Inc. by SD Biosensor, Inc., OraSure Technologies, Inc., Personalabs, Qiagen N.V., Quest Diagnostics, Inc., Randox Laboratories Ltd., Seegene Inc., Siemens Healthineers AG, Thermo Fisher Scientific Inc., Viatris Inc., and Wondfo Biotech Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the STD Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Blood Tests, Lumbar Puncture, Swab Tests, and Urine Tests.
  • Based on Product Type, market is studied across Instruments and Reagents & Kits.
  • Based on Test Settings, market is studied across Laboratory and Point of Care.
  • Based on Indication, market is studied across Chlamydia, Genital Herpes, Gonorrhea, Hepatitis B, HIV/AIDS, Human Papillomavirus, and Syphilis.
  • Based on End-user, market is studied across Diagnostic Centers and Hospitals & Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising incidence and prevalence of sexually transmitted diseases worldwide
      • 5.1.1.2. Increasing awareness about STDs through education campaigns
    • 5.1.2. Restraints
      • 5.1.2.1. Issues regarding strict regulatory guidelines for approval of STD testing products
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing technical advancements in STD disease diagnostics
      • 5.1.3.2. Increasing implementation of nationwide screening tests to encourage the adoption of STD testing
    • 5.1.4. Challenges
      • 5.1.4.1. Social stigma associated with visiting specialized STD testing clinics
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Increasing preference for swab tests for STD testing for their non-invasive nature
    • 5.2.2. Product Type: Need for high-throughput instruments for high-volume testing environments
    • 5.2.3. Test Settings: Preference for POC tests for their unmatched convenience and speed
    • 5.2.4. Indication: Rising occurrence of chlamydia and need for sophisticated testing technologies
    • 5.2.5. End-user: Expanding usage of STD testing at diagnostic centers for quick turnaround time
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. STD Testing Market, by Type

  • 6.1. Introduction
  • 6.2. Blood Tests
  • 6.3. Lumbar Puncture
  • 6.4. Swab Tests
  • 6.5. Urine Tests

7. STD Testing Market, by Product Type

  • 7.1. Introduction
  • 7.2. Instruments
  • 7.3. Reagents & Kits

8. STD Testing Market, by Test Settings

  • 8.1. Introduction
  • 8.2. Laboratory
  • 8.3. Point of Care

9. STD Testing Market, by Indication

  • 9.1. Introduction
  • 9.2. Chlamydia
  • 9.3. Genital Herpes
  • 9.4. Gonorrhea
  • 9.5. Hepatitis B
  • 9.6. HIV/AIDS
  • 9.7. Human Papillomavirus
  • 9.8. Syphilis

10. STD Testing Market, by End-user

  • 10.1. Introduction
  • 10.2. Diagnostic Centers
  • 10.3. Hospitals & Clinics

11. Americas STD Testing Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific STD Testing Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa STD Testing Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. Strategic Alliance Advances Self-Test Solutions for Sexually Transmitted Diseases
    • 14.3.2. imaware Expands its Portfolio through binx health's Consumer Division Purchase
    • 14.3.3. FDA Approves Advanced At-home Chlamydia and Gonorrhea Test
    • 14.3.4. British Startup Launches Tampon That Offers STI Screening
    • 14.3.5. iHealth Launches Home Collection Kit for STD Testing
    • 14.3.6. Aptitude Medical Systems' Innovative Approach to Combat Sexually Transmitted Infections (STIs)
    • 14.3.7. LifeCell International Revolutionizes STD and HPV Screening with At-Home Test Kits
    • 14.3.8. Breakthrough 20-Minute Test for Gonorrhea and Chlamydia by Linear Diagnostics
    • 14.3.9. US BioTek's Innovative At-Home Testing Solutions
    • 14.3.10. Visby Medical Achieves FDA Clearance for Advanced Sexual Health Diagnostic Tool
    • 14.3.11. Mylab Launches a Range of Rapid Tests for STDs
    • 14.3.12. Strategic Partnership between Maternova and MedMira Enhances Global Access to Rapid Diagnostic Tests for Infectious Diseases
    • 14.3.13. Innovative Partnership Tackles STI Spike Among Gen Z with At-Home Testing Solutions
    • 14.3.14. Meridian Bioscience Joins Forces with SD Biosensor and SJL Partners

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Accuquik by AdvaCare Pharma
  • 3. Alpine Biomedicals Pvt. Ltd.
  • 4. ARCpoint Labs
  • 5. Becton, Dickinson and Company
  • 6. Bio Lab Diagnostics (I) Private Limited
  • 7. Bio-Rad Laboratories, Inc.
  • 8. bioMerieux SA
  • 9. BioReference Health, LLC by OPKO HEALTH, INC.
  • 10. Danaher Corporation
  • 11. Daye Limited
  • 12. Everlywell, Inc.
  • 13. F. Hoffmann-La Roche Ltd.
  • 14. Getein Biotech, Inc.
  • 15. Grifols, S.A.
  • 16. Hologic, Inc.
  • 17. JAL Medical by OK Biotech Co. Ltd.
  • 18. Laboratory Corporation of America Holdings
  • 19. LifeCell
  • 20. Lorne Laboratories Limited by Calibre Scientific
  • 21. Meridian Bioscience Inc. by SD Biosensor, Inc.
  • 22. OraSure Technologies, Inc.
  • 23. Personalabs
  • 24. Qiagen N.V.
  • 25. Quest Diagnostics, Inc.
  • 26. Randox Laboratories Ltd.
  • 27. Seegene Inc.
  • 28. Siemens Healthineers AG
  • 29. Thermo Fisher Scientific Inc.
  • 30. Viatris Inc.
  • 31. Wondfo Biotech Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. STD TESTING MARKET RESEARCH PROCESS
  • FIGURE 2. STD TESTING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL STD TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL STD TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL STD TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL STD TESTING MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL STD TESTING MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL STD TESTING MARKET SIZE, BY TEST SETTINGS, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL STD TESTING MARKET SIZE, BY TEST SETTINGS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL STD TESTING MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL STD TESTING MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL STD TESTING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL STD TESTING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS STD TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. AMERICAS STD TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES STD TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 19. UNITED STATES STD TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC STD TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC STD TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA STD TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA STD TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. STD TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 25. STD TESTING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. STD TESTING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL STD TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL STD TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL STD TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. STD TESTING MARKET DYNAMICS
  • TABLE 7. GLOBAL STD TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL STD TESTING MARKET SIZE, BY BLOOD TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL STD TESTING MARKET SIZE, BY LUMBAR PUNCTURE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL STD TESTING MARKET SIZE, BY SWAB TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL STD TESTING MARKET SIZE, BY URINE TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL STD TESTING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL STD TESTING MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL STD TESTING MARKET SIZE, BY LABORATORY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL STD TESTING MARKET SIZE, BY POINT OF CARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL STD TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL STD TESTING MARKET SIZE, BY CHLAMYDIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL STD TESTING MARKET SIZE, BY GENITAL HERPES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL STD TESTING MARKET SIZE, BY GONORRHEA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL STD TESTING MARKET SIZE, BY HEPATITIS B, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL STD TESTING MARKET SIZE, BY HIV/AIDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL STD TESTING MARKET SIZE, BY HUMAN PAPILLOMAVIRUS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL STD TESTING MARKET SIZE, BY SYPHILIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL STD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL STD TESTING MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL STD TESTING MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS STD TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS STD TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS STD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS STD TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA STD TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA STD TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA STD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL STD TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL STD TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL STD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA STD TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA STD TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 49. CANADA STD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO STD TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 53. MEXICO STD TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 54. MEXICO STD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES STD TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES STD TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 59. UNITED STATES STD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 60. UNITED STATES STD TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC STD TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC STD TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC STD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 66. ASIA-PACIFIC STD TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA STD TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. AUSTRALIA STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. AUSTRALIA STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 70. AUSTRALIA STD TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 71. AUSTRALIA STD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA STD TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. CHINA STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. CHINA STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 75. CHINA STD TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 76. CHINA STD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA STD TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. INDIA STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. INDIA STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 80. INDIA STD TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 81. INDIA STD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA STD TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. INDONESIA STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. INDONESIA STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 85. INDONESIA STD TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 86. INDONESIA STD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN STD TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. JAPAN STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. JAPAN STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 90. JAPAN STD TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 91. JAPAN STD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA STD TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. MALAYSIA STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. MALAYSIA STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 95. MALAYSIA STD TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 96. MALAYSIA STD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES STD TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. PHILIPPINES STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. PHILIPPINES STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 100. PHILIPPINES STD TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 101. PHILIPPINES STD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE STD TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. SINGAPORE STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. SINGAPORE STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 105. SINGAPORE STD TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 106. SINGAPORE STD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA STD TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. SOUTH KOREA STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. SOUTH KOREA STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 110. SOUTH KOREA STD TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 111. SOUTH KOREA STD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN STD TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. TAIWAN STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. TAIWAN STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 115. TAIWAN STD TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 116. TAIWAN STD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND STD TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. THAILAND STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. THAILAND STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 120. THAILAND STD TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 121. THAILAND STD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM STD TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. VIETNAM STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. VIETNAM STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 125. VIETNAM STD TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 126. VIETNAM STD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA STD TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA STD TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA STD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA STD TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK STD TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. DENMARK STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. DENMARK STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 136. DENMARK STD TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 137. DENMARK STD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT STD TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. EGYPT STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. EGYPT STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 141. EGYPT STD TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 142. EGYPT STD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND STD TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. FINLAND STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. FINLAND STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 146. FINLAND STD TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 147. FINLAND STD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE STD TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. FRANCE STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. FRANCE STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 151. FRANCE STD TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 152. FRANCE STD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY STD TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. GERMANY STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. GERMANY STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 156. GERMANY STD TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 157. GERMANY STD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL STD TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 159. ISRAEL STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. ISRAEL STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 161. ISRAEL STD TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 162. ISRAEL STD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY STD TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. ITALY STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 165. ITALY STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 166. ITALY STD TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 167. ITALY STD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS STD TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 169. NETHERLANDS STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. NETHERLANDS STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 171. NETHERLANDS STD TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 172. NETHERLANDS STD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA STD TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 174. NIGERIA STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. NIGERIA STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 176. NIGERIA STD TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 177. NIGERIA STD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY STD TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 179. NORWAY STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. NORWAY STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 181. NORWAY STD TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 182. NORWAY STD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND STD TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. POLAND STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 185. POLAND STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 186. POLAND STD TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 187. POLAND STD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR STD TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 189. QATAR STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. QATAR STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 191. QATAR STD TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 192. QATAR STD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA STD TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 194. RUSSIA STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 195. RUSSIA STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 196. RUSSIA STD TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 197. RUSSIA STD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA STD TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 199. SAUDI ARABIA STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 200. SAUDI ARABIA STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 201. SAUDI ARABIA STD TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 202. SAUDI ARABIA STD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA STD TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH AFRICA STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 205. SOUTH AFRICA STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 206. SOUTH AFRICA STD TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 207. SOUTH AFRICA STD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN STD TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 209. SPAIN STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 210. SPAIN STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 211. SPAIN STD TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 212. SPAIN STD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN STD TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 214. SWEDEN STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 215. SWEDEN STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 216. SWEDEN STD TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 217. SWEDEN STD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND STD TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 219. SWITZERLAND STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 220. SWITZERLAND STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 221. SWITZERLAND STD TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 222. SWITZERLAND STD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY STD TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 224. TURKEY STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 225. TURKEY STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 226. TURKEY STD TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 227. TURKEY STD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES STD TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED ARAB EMIRATES STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED ARAB EMIRATES STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED ARAB EMIRATES STD TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED ARAB EMIRATES STD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM STD TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED KINGDOM STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED KINGDOM STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 236. UNITED KINGDOM STD TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 237. UNITED KINGDOM STD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 238. STD TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 239. STD TESTING MARKET, FPNV POSITIONING MATRIX, 2023